CTSP cancer-testis antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8470989
SERIAL NO

13462351

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to CTSP polypeptides and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis, prognosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, CTSP-1.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LUDWIG INSTITUTE FOR CANCER RESEARCH605 THIRD AVENUE NEW YORK NY 10158

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Camargo, Anamaria Aranha Sao Paulo, BR 3 1
de, Souza Sandro José São Paulo, BR 1 0
Parmigiani, Raphael Bessa São Paulo, BR 2 1
Vibranovski, Maria Dulcetti São Paulo, BR 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2024
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00